FDA adds strongest warning to Sarepta gene therapy
The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year. Sarepta Therapeutics' Elevidys will carry the FDA's strongest warning label about the risks of liver damage and liver failure, the agenc
(Associated Press, 2025-11-14T20:14:42Z)